EastCAHazellJWP. The suppression of palatal (or intratympanic) myoclonus by tinnitus masking devicesJ Laryngol1987;101:1230–4
3.
ObesoJAArtiedaJMarsdenCD. Different clinical presentations of myoclonus In:JankovicJTolosaE, eds. Parkinson's disease and movement disorders.Baltimore, Md.: Urban and Schwarzenberg,1988:263–7
4.
GuillainG. The syndrome of synchronous and rhythmic palato-pharyngo-laryngo-oculo-diaphragmatic myoclonusProc R Soc Med1938;31:1031–8
5.
BakheitABehanH. Palatal myoclonus successfully treated with clonazepamJ Neurol Neurosurg Psychiatry1990;53:806
6.
IwasakiYKinoshitaMIkedaKShiojimaT. Palatal myoclonus following Behcet's disease ameliorated by ceruletide, a potent analogue of CCK octapeptideJ Neurol Sci1991;105:12–3
7.
JabbariBScherokmanBGundersonCH. Treatment of movement disorders with trihexyphenidylMov Disord1989;4:202–12
8.
FitzgeraldDC. Palatal myoclonus — case reportLaryngoscope1984;94:217–9
9.
SandersDBMasseyEWBuckleyEG. Botulinum toxin for blepharospasm: Single-fiber EMG studiesNeurology1986;36:545–7
10.
JankovicJOrmanJ. Botulinum A toxin for cranial-cervical dystonia: A double-blind, placebo-controlled studyNeurology1987;37:616–23
11.
SingerCWeinerWJ. Dystonia In:JohnsonRTGriffinJW, eds. Current therapy in neurologic disease.4th ed.Philadelphia: B.C. Decker,1993:261–5
12.
BrinMF. Torticollis (cervical dystonia) In:JohnsonRTGriffinJW, eds. Current therapy in neurologic disease.4th ed.Philadelphia: B.C. Decker,1993:266–70
13.
HambletonP. Clostridium botulinum toxins: a general review of involvement in disease, structure, mode of action and preparation for clinical useJ Neurol1992;239:16–20
14.
SaeedSRBrookesGB. The use of Clostridium botulinum toxin in palatal myoclonus. A preliminary reportJ Laryngol Otol1993;107:208–10
